| Income Statement | 2025-09-30 | 2025-03-31 | 2024-09-30 | |
|---|---|---|---|---|
| Interest and other income | 93,765 | - | 57,094 | |
| Loss before income tax expense | -1,726,899 | 0 | -1,677,868 | |
| Net loss for the period | -1,726,899 | - | -1,677,868 | |
| Basic (in dollars per share) | -0.44 | -1.94 | -2.71 | |
| Basic (in shares) | 3,954,549 | 1,095,973 | 620,127 | |
| Diluted (in dollars per share) | -0.44 | -1.94 | -2.71 | |
| Diluted (in shares) | 3,954,549 | 1,095,973 | 620,127 | |
InMed Pharmaceuticals Inc. (INM)
InMed Pharmaceuticals Inc. (INM)